We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
KITOXAN® - The First Venom Fractions Library for Drug Discovery
News

KITOXAN® - The First Venom Fractions Library for Drug Discovery

KITOXAN® - The First Venom Fractions Library for Drug Discovery
News

KITOXAN® - The First Venom Fractions Library for Drug Discovery

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "KITOXAN® - The First Venom Fractions Library for Drug Discovery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

In order to give discovery researchers an access to invaluable peptides Latoxan and Atheris decided to join their know-how to develop and market KITOXAN®.

It is a library of venom fractions available in 96-well plates. Venoms have been first cleared from cytotoxic enzymes and split up in 20 fractions each. Wells are expected to contain 5 to 10 peptides so as to facilitate the identification of the active peptide once a hit is found out. Well-plates are filled with 80 fractions of 4 venoms, corresponding to about 500 different peptides in total.

The KITOXAN®-V01 Library is the first set of 5 well-plates of a total 400 venom fractions from 20 species: snakes, scorpions, amphibians, spider. In total KITOXAN-V01 allows the screening of pharmacological activity of over 2500 natural peptides.

Additional sets of well-plates will be progressively developped to give scientists a larger scope among venoms diversity. With 100’000 venomous species in the world and millions of potential hits for drug discovery it might be a long way for KITOXAN®.

Advertisement